Mitochondrial electron transport chain deficiency, cardiomyopathy, and long-term cardiac transplant outcome

Pediatric Transplantation

Volumn 16, Issue 3, 2012, Pages 265-268

  Golden, Alana S ^a   Law, Yuk M ^b   Shurtleff, Hillary ^a   Warner, Molly ^a   Saneto, Russell P ^a  

^a SEATTLE CHILDREN S HOSPITAL   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

cardiac transplantation; cardiomyopathy; electron transport chain; mitochondrial disease

Indexed keywords

ACYLCARNITINE; CYCLOSPORIN; DICARBOXYLIC ACID; GLYCINE; MYCOPHENOLIC ACID; TACROLIMUS;

ADULT; ARTICLE; CARDIAC GRAFT REJECTION; CASE REPORT; CHILD; COMPLEX III DEFICIENCY; CONGESTIVE CARDIOMYOPATHY; CYTOCHROME C OXIDASE DEFICIENCY; DEFIBRILLATOR; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG SUBSTITUTION; DRUG TOLERANCE; DRUG WITHDRAWAL; ECHOVIRUS INFECTION; ELECTRON TRANSPORT; ENZYME ANALYSIS; FATIGUE; FATTY ACID BLOOD LEVEL; FEMALE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GINGIVA HYPERTROPHY; GRAFT REJECTION; HEART FAILURE; HEART MUSCLE BIOPSY; HEART TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LABORATORY TEST; LONG TERM CARE; MALE; MIGRAINE; MOTOR DYSFUNCTION; MUSCLE BIOPSY; MUSCLE CRAMP; MUSCLE HYPOTONIA; OXIDATIVE PHOSPHORYLATION; PECTORALIS MAJOR MUSCLE; RESPIRATORY TRACT INFECTION; SCHOOL CHILD; STENT; TREATMENT OUTCOME; VASCULAR DISEASE; VASTUS LATERALIS MUSCLE;

CARDIOMYOPATHIES; CHILD; CHILD, PRESCHOOL; ELECTRON TRANSPORT; FEMALE; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MITOCHONDRIAL DISEASES; MUSCLE, SKELETAL; OUTCOME ASSESSMENT (HEALTH CARE); OXIDATIVE PHOSPHORYLATION; RETROSPECTIVE STUDIES; SPECTROPHOTOMETRY; TIME FACTORS; TREATMENT OUTCOME;

EID: 84859699756     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2011.01635.x     Document Type: Article

References (23)

1. Smeitink JA, Zeviani M, Turnbull DM, Jackobs HT,. Mitochondrial medicine: A metabolic perspective on the pathology of oxidative phosphorylation disorders. Cell Metab 2006: 3: 9-13.
2. Holmgren D, Wahlander H, Erikkson BO, Oldforss A, Holme E, Tulinius M,. Cardiomyopathy in children with mitochondrial disease: Clinical course and cardiological findings. Eur Heart J 2003: 24: 280-288.
3. Scaglia F, Towbin JA, Craigen WJ, et al., Clinical spectrum, morbidity, and mortality in 113 pediatric patients with mitochondrial disease. Pediatrics 2004: 114: 925-931.
4. Debray FG, Lambert M, Chevalier I, et al., Long-term outcome and clinical spectrum of 73 pediatric patients with mitochondrial diseases. Pediatrics 2007: 119: 722-733.
5. Bernier FP, Boneh A, Dennett X, Chowe CW, Cleary MA, Thorburn DR,. Diagnostic criteria for respiratory chain disorders in adults and children. Neurology 2002: 59: 1406-1411.
6. Haas RH, Parikh S, Falk MJ, et al., The in-depth evaluation of suspected mitochondrial disease. Mol Genet Metab 2008: 94: 16-37.
7. Haas RH, Parikh S, Falk MJ, et al., Mitochondrial disease: A practical approach for primary care physicians. Pediatrics 2007: 120: 1326-1333.
8. Kirby DM, Crawford M, Cleary MA, Dahl HHM, Dennett X, Thorburn DR,. Respiratory chain complex I deficiency: An underdiagnosed energy generation disorder. Neurology 1999: 52: 1255-1264.
9. Marin-Garcia J, Goldenthal MJ, Filano JJ,. Cardiomyopathy associated with neurologic disorders and mitochondrial phenotype. J Child Neurol 2002: 17: 759-765.
10. Bhati RS, Sheridan BC, Mill MR, Selzman CH,. Heart transplantation for progressive cardiomyopathy as a manifestation of MELAS syndrome. J Heart Lung Transplant 2005: 24: 2286-2289.
11. Bonnet D, Rustin P, Rotig A, et al., Heart transplantation in children with mitochondrial cardiomyopathy. Heart 2001: 86: 570-573.
12. Bussieres LM, Pfugfelder PW, Guiraudon C, et al., Exercise responses after cardiac transplantation in mitochondrial myopathy. Am J Cardiol 1993: 71: 1003-1006.
13. Morgan KG, Hasleton PS, Brooks NH, Curry A, Walter J, Cumming WJK,. Mitochondrial cardiomyopathy. Eur Heart J 1996: 17: 1600.
14. Melacini P, Gambino A, Caforio A, et al., Heart transplantation in patients with inherited myopathies associated with end-stage cardiomyopathy: Molecular and biochemical defects on cardiac and skeletal muscle. Transplant Proc 2001: 33: 1596-1599.
15. Schmauss D, Sodian R, Klopstock T, et al., Cardiac transplantation in a 14-yr-old patient with mitochondrial encephalomyopathy. Pediatr Transplant 2007: 11: 560-562.
16. Limongelli G, Tome-Esteban M, Dejthevaporn C, Rahman S, Hanna MG, Elliott PM,. Prevalence and natural history of heart disease in adults with primary mitochondrial respiratory chain disease. Eur J Heart Fail 2010: 12: 114-121.
17. Santorelli FM, Gagliardi MG, Dionisi-Vicii C, et al., Hypertrophic cardiomyopathy and mtDNA depletion. Successful treatment with heart transplantation. Neuromuscul Disord 2002: 12: 56-59.
18. Rosca MG, Hoppel CL,. Mitochondria in heart failure. Cardiovasc Res 2010: 88: 40-50.
19. Lee WS, Sokol RJ,. Mitochondrial hepatopathies: Advances in genetics and pathogenesis. Hepatology 2007: 45: 1555-1565.
20. Chinnock RE, Freier MC, Ashwal S, et al., Developmental outcomes after pediatric heart transplantation. J Heart Lung Transplant 2008: 27: 1079-1084.
21. Kirk R, Edwards LB, Kucheryavaya AY, et al., The Registry of the International Society for Heart and Lung Transplantation: 13th official pediatric heart transplantation report-2010. J Heart Lung Transplant 2010: 10: 1083-1141.
22. Rodriguez LC, Araujo CR, Posleman SE, Rey Mdel R,. Hepatotoxic effect of cyclosporin A in the mitochondrial respiratory chain. J Appl Toxicol 2007: 27: 310-317.
23. Han SY, Chang EJ, Choi HJ, et al., Effect of tacrolimus on the production of oxygen free radicals in hepatic mitochondria. Transplant Proc 2006: 38: 2242-2243.